Dr. Brian G.M. Durie discusses key takeaways from the annual conference and explains how this new and important information relates to myeloma patients, caregivers, and other members of the myeloma community.
ASH is the American Society of Hematology. This annual conference welcomed more than 30,000 healthcare professionals from around the world this past December, 2018.
Educational grant provided by:
Celgene, Karyopharm, Sanofi-Genzyme, Takeda Oncology